Status:
NOT_YET_RECRUITING
The Neurofibromatosis-associated Tumor Biobank
Lead Sponsor:
Ren tingting
Conditions:
Neurofibromatoses
Eligibility:
All Genders
Brief Summary
Neurofibromatosis-associated Tumor is very rare bone tumor. The investigator set up the biobank to ensure every patient has the chance to participate in future research
Detailed Description
Samples of blood and other stored material such as slides,frozen tissues or leftover diagnostic material. Questionnaire information, including health history, growth and development, physical activit...
Eligibility Criteria
Inclusion
- Proband Inclusion criteria: A diagnosis or suspected diagnosis of neurofibromatosis-associated tumor Family member inclusion criteria: Biological parents and full biological siblings of a case diagnosed with neurofibromatosis-associated tumor
Exclusion
- non-asian
Key Trial Info
Start Date :
March 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2028
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03359304
Start Date
March 1 2018
End Date
March 1 2028
Last Update
December 2 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.